In its continued bid to waylay the launch of MSN Pharmaceuticals’ proposed Entresto generic, Novartis has told a federal ...

The Council is now set to begin negotiations with the European Parliament on the package, after which the rules would be ...

Researchers have zeroed in on yet another possible ocular concern for diabetes patients who take popular GLP-1 therapies in a ...

Days after FDA Commissioner Marty Makary said that the agency planned to review the safety of abortion pill mifepristone, ...

The PD-(L)1xVEGF field had a roller coaster week marked by an imperfect readout and a potentially $11 billion deal. | The PD- ...

Bayer has taken another step toward achieving its €3 billion peak sales estimate for androgen receptor inhibitor Nubeqa, ...

Each year, the American Society of Clinical Oncology annual meeting brings together the biggest names and brightest minds in ...

Argenx has signed on as an early partner to a newly launched initiative from media companies NBCUniversal Local and Digital ...

Orca Bio is preparing to make a splash in the cell therapy market. | Orca Bio is preparing to make a splash in the cell ...

Amneal Pharmaceuticals is recalling three lots of sulfamethoxazole/trimethoprim tablets because of microbial contamination ...

With the deal, Sanofi gains Blueprint’s portfolio of rare immunological disease treatments, including systemic mastocytosis ...

Drugmakers and contract manufacturers are responding to the booming demand for antibody-drug conjugates, with multiple ...